With all the uncertainty of COVID-19, we hope you are safe and in good health. Ozgene is still here to meet your research needs.

Engineering the mouse genome to model human disease for drug discovery.

 Back to publications

2010

Methods Mol Biol 2010;602:55

Engineering the mouse genome to model human disease for drug discovery.

Koentgen, F;Naf, D.;Suess, G

Ozgene Pty Ltd, Bentley, WA, Australia.

Service type: Not applicable

Abstract

Genetically engineered mice (GEM) have become invaluable tools for human disease modeling and drug development. Completion of the mouse genome sequence in combination with transgenesis and gene targeting in embryonal stem cells have opened up unprecedented opportunities. Advanced technologies for derivation of GEM models will be introduced and discussed.

View Publication